Abstract P1-11-04: Neoadjuvant Z-endoxifen for Premenopausal Estrogen Receptor (ER)+, Human Epidermal Growth Factor Receptor (HER2)- Breast Cancer (BC): Evaluation of the Pharmacokinetic (PK) Run-in for the EVANGELINE StudyMatthew Bidwell Goetz, Steven C. Quay, Joel M. Reid et al.|Clinical Cancer Research|2025Cited by 0